Capital-starved Yes Bank tanks 85 per cent
Capital-starved Yes Bank tanks 85 per cent

Capital-starved Yes Bank tanks 85 per cent

Amir Shaikh Article rating: 4.4

Capital-starved Yes Bank has tumbled more than 85 per cent on the bourses today as the country's central bank has imposed a moratorium on the bank and capped withdrawals at Rs 50,000 per account 

Dr Reddys Laboratories plunge post USFDA audit in Plant-5
Dr Reddys Laboratories plunge post USFDA audit in Plant-5

Dr Reddys Laboratories plunge post USFDA audit in Plant-5

Avalokita Pandey Article rating: 4.7

The shares of Dr Reddy’s Laboratories plunged today after the multinational pharmaceutical company announced on Thursday that an audit has been conducted at its API manufacturing Plant-5 in Telangana by USFDA, after which, the agency issued a form 483 with three observations.

The downside protection myth!
The downside protection myth!

The downside protection myth!

Henil Shah Article rating: 3.0

Downside risk is something that investors look for reducing the risk of loss during the worst time and they feel active managers can do it better. This is a myth that needs to get busted.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Abhishek Kapoor Article rating: 5.0

The market opened in the red on March 6, 2020, overall volumes in futures & options currently stand at 5,72 crore contracts with a turnover of Rs. 37,12,514.30 crore.

Stocks with buying interest
Stocks with buying interest

Stocks with buying interest

Abhishek Kapoor Article rating: 4.2

The market opened in the red on March 6, 2020, overall volumes in futures & options currently stand at 5,72 crore contracts with a turnover of Rs. 37,12,514.30 crore.

Lupin launches generic version of Vimovo in US
Lupin launches generic version of Vimovo in US

Lupin launches generic version of Vimovo in US

Anthony Fernandes Article rating: 4.0

Pharma major Lupin Limited announced the launch of an authorised generic version of Horizon Therapeutics PLC's Vimovo delayed action release tablets, 375 mg/20 mg and 500 mg/ 20 mg in US.

Performance perspective of Indian Equity Market
Performance perspective of Indian Equity Market

Performance perspective of Indian Equity Market

Shashikant Singh Article rating: 3.0

The Indian equity market, which was already struggling from the impact of the coronavirus, has another event to deal with, which has led to the sharp correction in the equity market.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Abhishek Kapoor Article rating: 3.5

The market opened in the red on March 6, 2020. The previous trading session witnessed the Sensex going up by 61.13 points to end at 38,470.61 and the Nifty was up by 18 points to close at 11,269.00.

Ten stocks close to their 52-week low
Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Abhishek Kapoor Article rating: 5.0

The market opened in the red on March 6, 2020. The previous trading session witnessed the Sensex going up by 61.13 points to end at 38,470.61 and the Nifty was up by 18 points to close at 11,269.00.

Another Black Friday for markets!
Another Black Friday for markets!

Another Black Friday for markets!

Karan Dsij Article rating: 4.7

Early signs from SGX Nifty indicate that it could be another Black Friday like the previous week, where Indian markets had cracked sharply. Our call for the day would be waiting for the market to settle after initial volatility, as there could be an initial reaction to Coronavirus, which is taking a toll on global economy and no one has the answer where this Coronavirus is heading and that’s the scary part.

RSS
First23492350235123522354235623572358Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR